-
Fund Dashboard
- Holdings
Biotechnology Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 968.84 k | 4.91 k shares | 8.78 | Common equity | Long | USA |
AMGN Amgen Inc. | 665.69 k | 2.07 k shares | 6.03 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 517.54 k | 6.17 k shares | 4.69 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 443.69 k | 954.00 shares | 4.02 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 413.14 k | 393.00 shares | 3.74 | Common equity | Long | USA |
CTVA Corteva, Inc. | 330.87 k | 5.63 k shares | 3.00 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 304.46 k | 1.11 k shares | 2.76 | Common equity | Long | USA |
AstraZeneca plc
|
296.06 k | 3.80 k shares | 2.68 | Common equity | Long | UK |
BIIB Biogen Inc. | 270.60 k | 1.40 k shares | 2.45 | Common equity | Long | USA |
MRNA Moderna, Inc. | 268.86 k | 4.02 k shares | 2.44 | Common equity | Long | USA |
ILMN Illumina, Inc. | 240.48 k | 1.84 k shares | 2.18 | Common equity | Long | USA |
First American Government Obligations Fund - Class X | 214.68 k | 214.68 k shares | 1.94 | Short-term investment vehicle | Long | USA |
UTHR United Therapeutics Corporation | 206.77 k | 577.00 shares | 1.87 | Common equity | Long | USA |
NTRA Natera, Inc. | 197.79 k | 1.56 k shares | 1.79 | Common equity | Long | USA |
Royalty Pharma plc
|
194.89 k | 6.89 k shares | 1.77 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 186.15 k | 1.63 k shares | 1.69 | Common equity | Long | USA |
VTRS Viatris Inc. | 184.87 k | 15.92 k shares | 1.67 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 180.11 k | 2.64 k shares | 1.63 | Common equity | Long | USA |
INSM Insmed Incorporated | 176.00 k | 2.41 k shares | 1.59 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 171.22 k | 1.37 k shares | 1.55 | Common equity | Long | USA |
INCY Incyte Corporation | 170.74 k | 2.58 k shares | 1.55 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 169.89 k | 2.42 k shares | 1.54 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 168.22 k | 1.46 k shares | 1.52 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 150.14 k | 3.08 k shares | 1.36 | Common equity | Long | Cayman Islands |
Alkermes plc
|
148.99 k | 5.32 k shares | 1.35 | Common equity | Long | USA |
BNTX BioNTech SE | 142.05 k | 1.20 k shares | 1.29 | Common equity | Long | Germany |
ARGX argenx SE | 141.48 k | 261.00 shares | 1.28 | Common equity | Long | Netherlands |
RVMD Revolution Medicines, Inc. | 139.22 k | 3.07 k shares | 1.26 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 136.63 k | 5.27 k shares | 1.24 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 135.07 k | 1.85 k shares | 1.22 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
135.02 k | 2.87 k shares | 1.22 | Common equity | Long | USA |
Jazz Pharmaceuticals plc
|
134.25 k | 1.21 k shares | 1.22 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 131.71 k | 2.30 k shares | 1.19 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 126.87 k | 2.00 k shares | 1.15 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 122.92 k | 2.33 k shares | 1.11 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 121.45 k | 1.31 k shares | 1.10 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 121.21 k | 2.64 k shares | 1.10 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd. | 117.97 k | 10.22 k shares | 1.07 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 117.30 k | 2.93 k shares | 1.06 | Common equity | Long | USA |
MEDP Medpace Holdings, Inc. | 109.49 k | 328.00 shares | 0.99 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 109.16 k | 1.97 k shares | 0.99 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 102.05 k | 2.00 k shares | 0.92 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 95.44 k | 1.06 k shares | 0.86 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 92.75 k | 3.64 k shares | 0.84 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 92.31 k | 2.57 k shares | 0.84 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 91.62 k | 3.92 k shares | 0.83 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 87.84 k | 8.23 k shares | 0.80 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 83.22 k | 1.84 k shares | 0.75 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 82.40 k | 8.78 k shares | 0.75 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 80.84 k | 2.18 k shares | 0.73 | Common equity | Long | USA |
GH Guardant Health, Inc. | 80.27 k | 3.50 k shares | 0.73 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 79.79 k | 780.00 shares | 0.72 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 78.10 k | 2.71 k shares | 0.71 | Common equity | Long | USA |
NVAX Novavax, Inc. | 76.39 k | 6.05 k shares | 0.69 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 75.08 k | 3.88 k shares | 0.68 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 73.10 k | 3.56 k shares | 0.66 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 68.75 k | 4.47 k shares | 0.62 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 68.66 k | 2.14 k shares | 0.62 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 67.94 k | 10.31 k shares | 0.62 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 67.63 k | 2.37 k shares | 0.61 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 67.47 k | 9.79 k shares | 0.61 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 62.75 k | 5.63 k shares | 0.57 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 57.67 k | 2.35 k shares | 0.52 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 55.88 k | 307.00 shares | 0.51 | Common equity | Long | USA |
Madrigal Pharmaceuticals, Inc. | 55.18 k | 260.00 shares | 0.50 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 51.01 k | 1.78 k shares | 0.46 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 36.68 k | 8.90 k shares | 0.33 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 31.41 k | 4.35 k shares | 0.28 | Common equity | Long | USA |
J.P. Morgan Securities LLC | 30.02 k | 30.02 k principal | 0.27 | Repurchase agreement | Long | USA |
BofA Securities, Inc. | 24.80 k | 24.80 k principal | 0.22 | Repurchase agreement | Long | USA |